FDA Recommends IVC Filter Removal When Embolism Protection No Longer Needed

On August 9, 2010, the U.S. Food and Drug Administration (“FDA”) issued a safety communication about the risks of adverse events concerning retrievable IVC filters. In the communication, FDA recommended physicians consider removing the IVC filter “as soon as protection from [pulmonary embolism] is no longer needed.” The FDA further recommended ongoing followup and referral for IVC … Read more

Talc, Baby Powder And Cancer Risk

Women who used Baby Powder or similar talcum products have filed lawsuits, alleging baby powder caused their ovarian cancer. In 1971, a scientific study found talc particles in tumor tissue, and noted the “close association” between talc and the “asbestos group” of minerals: An extraction-replication technique was used to examine tissue from patients with ovarian … Read more

24 Mesothelioma and Asbestos Lung Cancer Facts

The United States government did not start tracking mesothelioma as a unique cause of death until 1999, thus the statistical results earlier than 1999 include estimates. Below are twenty-four facts about Mesothelioma and asbestos lung cancer diagnoses, mortality, treatment, exposure, and lawsuits. Please visit this page for more information on mesothelioma and asbestos lung cancer … Read more

Byetta Cancer Risk FDA Warning, Lawsuits Filed

Consumers should be aware the FDA has issued a warning concerning Byetta™ and its link to increased pancreatic cancer risk and increased thyroid cancer risk. As we have have previously reported, there may be a link between Byetta and increased cancer risk. Byetta is a prescription drug for the treatment of Type 2 diabetes, and was approved by the … Read more

Januvia Cancer Risk FDA Warning, Lawsuits Filed

Patients should be aware the FDA has issued a warning concerning Januvia™ and increased pancreatic cancer risk and increased thyroid cancer risk. As we previously reported, there may be a link between Januvia and increased cancer risk. Januvia, also known as sitagliptin phosphate, is used to treat Type 2 diabetes. The FDA approved Januvia in March 2006. … Read more

InFuse Bone Graft Lawsuits

The Medtronic InFuse Bone Graft was approved by the Food & Drug Administration (FDA) as a bone growth product to be utilized in anterior lumbar fusion surgeries. InFuse contains a protein which is designed to stimulate bone growth in patients who suffer from conditions like degenerative disc disease. However, Medtronic has been the subject of … Read more